Stability by design
MiCo's platform work is developed for formulations where ingredient stability is a key design constraint from the beginning, not a late-stage correction.
Many nutritional ingredients are difficult to combine in one convenient format. Some are sensitive to storage conditions. Others are difficult to use consistently when they require multiple capsules, powders, sachets, or separate routines.
MiCo's technology work is developed around a simple idea: nutritional formulations should be easier to take, easier to combine, and easier to design for real-life use.
The public layer of this work is intentionally simple. Detailed formulation architecture, process parameters, and validation data remain protected as internal know-how and are shared only in appropriate business or regulatory contexts.
MiCo's platform work is developed for formulations where ingredient stability is a key design constraint from the beginning, not a late-stage correction.
The technology base supports product architectures in which different nutritional components can be brought together in a single serving format.
The first MiCo products use a small liquid format because daily nutritional support should be practical, especially when appetite, routine, or swallowing comfort may be limiting.
MiCo's technology work is being developed with repeatable production logic, quality control, and future category expansion in mind.
The first application focuses on microbiome-oriented supportive nutrition. Future applications and parallel technology directions may include other human nutrition segments, selected animal health concepts, and additional areas where liquid delivery, ingredient compatibility, and user compliance are important.
Focused on practical daily nutritional support in a liquid serving format.
A public-facing category fit for a platform designed around sensitive biological and nutritional components.
MiCo may adapt existing platform logic and develop additional technology approaches after the first commercial use case is validated.
The first MiCo product line applies LipoBiomix® to small-volume liquid nutritional shots.
Each product is designed around a different routine need, while sharing the same public platform logic: advanced nutrition in a simple daily format. Other MiCo technology directions remain in development for future formats.
The first public expression of a broader MiCo technology base.
A simple format designed for recurring use as part of a daily nutrition habit.
A product direction built around a more concentrated routine need.
A liquid-format expression of MiCo's first microbiome-oriented product direction.
MiCo publicly describes selected technology directions, including LipoBiomix® as its first named delivery platform. The underlying formulation logic, process design, ingredient architecture, and validation details across MiCo's technology work are protected through a combination of know-how, documentation, and intellectual property strategy.
For partners, investors, or technical stakeholders, more detailed information about selected technologies may be discussed under appropriate confidentiality conditions.